FDA Approved: METHOTREXATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approves a supplemental application for Methotrexate by Hikma Pharmaceuticals USA Inc., enabling a new generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Breast Cancer
• Choriocarcinoma
• Head and Neck Squamous Cell Carcinoma
• Osteosarcoma
• Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

SUPPL AP for METHOTREXATE (METHOTREXATE)